
Dr. Osols: ... meaning that the inflamed tissue would be the only tissue acted on by the micro-machines. No side-effects of any kind, unless the patient had a metal allergy, but even then we could use this very same technology to treat that condition as well.
Doctor Osols of the ASE Biotech Research Project Agency finished her presentation. She and Doctor Comeau of the CSL were briefing Empress Xianghua on their research on using nano-bots to attack inflammation.

Dr. Maxwell: I must admit your approach to this problem is unique, but the effects of your technology are too close to how our patented treatment, Antifeu, works.

Dr. Sato: I'm sorry, but I must agree with my client. I don't think we can allow your further development of this line of research, or you'll merely end up cloning Antifeu.

































